<DOC>
	<DOCNO>NCT01519401</DOCNO>
	<brief_summary>The estrogenic component estro-progestin ( EP ) responsible negative impact metabolic lipid assessment woman polycystic ovary syndrome ( PCOS ) . The objective study compare effect long term administration two EP combination , contain progestin ( 3 mg drospirenone ) different dose ethinyl-estradiol ( EE ) ( 20 vs 30 μg ) clinical endocrine-metabolic parameter normal weight PCOS woman . The investigator enrol 30 patient , randomly allocate group A ( 20 µg EE - 3 mg DRSP ) 15 group B ( 30 µg EE - 3 mg DRSP ) . Hirsutism score evaluation , hormonal assay , oral glucose tolerance test , euglycaemic hyperinsulinaemic clamp lipid profile perform baseline 6 12 month therapy .</brief_summary>
	<brief_title>Effect Two Different Dosages Ethinyl-estradiol Association With Drospirenone Women With Polycystic Ovary Syndrome .</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>normal weight woman Polycystic ovary syndrome , diagnose accordance Rotterdam Consensus Conference Criteria 2003. pregnancy past history cardiovascular disease , diabetes mellitus ( impaired glucose tolerance determine standard 75 g oral glucose tolerance test ) , hypertension significant liver renal impairment hormonal dysfunction ( hypothalamic , pituitary , thyroidal adrenal cause clinical sign ) neoplasms unstable mental illness</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>PCOS</keyword>
	<keyword>drospirenone ethinylestradiol</keyword>
	<keyword>androgen</keyword>
	<keyword>metabolism</keyword>
</DOC>